4,7-Dibromo-2-(2-ethylhexyl)isoindoline-1,3-dione

Catalog No. :
ACFUAT096
CAS No. :
863027-98-9
Molecular Formula :
C16H19Br2NO2
Molecular Weight :
417.14

IUPAC Name:4,7-dibromo-2-(2-ethylhexyl)isoindoline-1,3-dione

4,7-Dibromo-2-(2-ethylhexyl)isoindoline-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg99%$219.00Login to see priceInquiryInquiry
250mg99%$438.00Login to see priceInquiryInquiry
1g99%$875.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,7-Dibromo-2-(2-ethylhexyl)isoindoline-1,3-dione
IUPAC Name4,7-dibromo-2-(2-ethylhexyl)isoindoline-1,3-dione
Molecular FormulaC16H19Br2NO2
Molecular Weight417.14
SMILESO=C1N(C(C2=C(C=CC(Br)=C21)Br)=O)CC(CC)CCCC
InChI KeyMFVRURWCDDILCC-UHFFFAOYSA-N
Synonym4,7-DibroMo-2-(2-ethylhexyl)isoindoline-1,3-dione;1H-Isoindole-1,3(2H)-dione, 4,7-dibromo-2-(2-ethylhexyl)-;N-(2-ethylhexyl)-3,6-dibromophthalimide;IDA-2Br
CAS No.863027-98-9
PubChem CID59523077

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFUAT096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOZEC674 route compound structure diagram
    ACOZEC67418908-66-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFUAT096 route product structure diagram
    ACFUAT096863027-98-9
Inquiry

2. ACFUAT096 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFUAT096 route product structure diagram
    ACFUAT096863027-98-9
Inquiry

Comments (0)